2 ASX All Ords shares cracking new 52-week highs on Tuesday

Do these healthcare shares have a place in your portfolio?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Tuesday is shaping up to be rough one for many All Ordinaries Index (ASX: XAO) shares. Fortunately, though, not all companies that call the index home are suffering.

Indeed, two are soaring into the green to crack new 52-week highs.

Right now, the All Ords is down 0.2%, trading at 7,137.1 points.

So, which stocks are bucking the trend to reach long-forgotten heights? Let's take a look.

Two people climb to the summit and raise their arms in success as the sun rises brightly over the mountains.

Image source: Getty Images

2 All Ords shares trading at 12-month highs

The first All Ords share posting a new 52-week high today is medical device developer Polynovo Ltd (ASX: PNV).

It's soaring 7.83% at the time of writing to trade at $2.48. However, earlier today, it hit $2.50 – marking an 8.7% gain and the highest the stock has been in 18 months.

Interestingly, there's been no news from the healthcare favourite to explain today's rise.

In fact, the last time the market heard price-sensitive news from Polynovo was in mid-December when the company announced the end of a $53 million capital raise – offering new shares for $1.90 apiece.

Thus, those who got in on the raise have already seen a 30% return on investment (ROI).

Joining Polynovo in posting a new 52-week high today is fellow All Ords healthcare share Aroa Biosurgery Ltd (ASX: ARX).

It reached its highest point since October 2021 earlier today, leaping to $1.175 – 2.2% higher than its previous close. It has since slipped slightly to $1.1725, representing a 1.96% gain.

Also, like Polynovo before it, the company hasn't released any news to explain its latest gain.

The last piece of price-sensitive news from Aroa Biosurgery, detailing its half-year performance, dropped in late November.

Then, the company announced its product sales grew 44% year-on-year while its normalised earnings before interest, tax, depreciation, and amortisation (EBITDA) was positive.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended PolyNovo. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on 52-Week Highs

A graphic image of three upward pointing arrows with smoke coming from their bottoms, indicating the arrows are taking off just like the Althea share price today
52-Week Highs

3 ASX 200 stocks smashing new 52-week-plus highs today

These three large-cap ASX 200 shares just broke into new 52-week-plus high territory.

Read more »

Three people jumping cheerfully in clear sunny weather.
52-Week Highs

3 ASX dividend favourites are hitting 52-week highs today. Are investors getting defensive?

Investors are buying these ASX dividend shares today.

Read more »

Happy man on a supermarket trolley full of groceries with a woman standing beside him.
52-Week Highs

Are Woolworths shares still a buy at a 52-week high?

Is it too late to buy the supermarket giant's shares? Let's dig deeper into things.

Read more »

A couple in a supermarket laugh as they discuss which fruits and vegetables to buy
52-Week Highs

This ASX 200 giant just hit a 52-week high. Is it getting too expensive?

This defensive ASX 200 stock is flying this year.

Read more »

A man in a supermarket strikes an unlikely pose while pushing a trolley, lifting both legs sideways off the ground and looking mildly rattled with a wide-mouthed expression.
Consumer Staples & Discretionary Shares

Woolworths shares soar to new multi-year high: Buy, sell or hold?

After a bumpy start to the year, the supermarket giant's shares are back in favour with investors.

Read more »

a person stands arms outstretched on the top of a mountain with a beautiful sunrise in the sky
52-Week Highs

3 ASX 200 shares, including Macquarie and BHP, smashing new 52-week-plus highs today

Investors just sent Macquarie, BHP, and this top ASX 200 share to new one-year-plus highs. But why?

Read more »

A young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
52-Week Highs

This ASX tech stock just hit a 52-week high after soaring 35% in a month

Investors have sent this ASX tech share to a yearly high.

Read more »

Children skipping and jumping up a hill.
52-Week Highs

QBE shares just hit a decade high. Is it too late to buy?

QBE shares just hit decade highs after a strong start to 2026.

Read more »